Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The mechanisms involved in the initiation and maintenance of skin inflammation in atopic dermatitis (AD) are poorly understood. Recent data suggest that the pattern of cytokines expressed locally plays a critical role in modulating the nature of tissue inflammation. In this study, we used in situ hybridization to investigate the expression of interleukin 4 (IL-4), IL-5, and interferon-gamma (IFN-gamma) messenger RNA (mRNA) in skin biopsies from acute and chronic skin lesions of patients with AD. As compared with normal control skin or uninvolved skin of patients with AD, acute and chronic skin lesions had significantly greater numbers of cells that were positive for mRNA, IL-4 (P < 0.01), and IL-5 (P < 0.01), but not for IFN-gamma mRNA expressing cells. However, as compared with acute AD skin lesions, chronic AD skin lesions had significantly fewer IL-4 mRNA-expressing cells (P < 0.01), but significantly greater IL-5 mRNA (P < 0.01). T cells constituted the majority of IL-5-expressing cells in acute and chronic AD lesions. Chronic lesions also expressed significantly greater numbers of activated EG2+ eosinophils than acute lesions (P < 0.01). These data indicate that although acute and chronic AD lesions are associated with increased activation of IL-4 and IL-5 genes, initiation of acute skin inflammation in AD is associated with a predominance of IL-4 expression whereas maintenance of chronic inflammation is predominantly associated with increased IL-5 expression and eosinophil infiltration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Diagnostic features of atopic dermatitis
Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086
Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma
Robinson, D. S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A. M., Corrigan, C., Durham, S. R., & Kay, A. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260504 · Cited by 2,768
Self-citationIL‐4 directs the development of Th2‐like helper effectors
Swain, S. L., Weinberg, A. D., English, M., & Huston, G. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.11.3796 · Cited by 1,254
Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores
Plaut, M., Pierce, J. H., Watson, C. J., Hanley-Hyde, J., Nordan, R. P., & Paul, W. E. (1989) · Nature · doi:10.1038/339064a0 · Cited by 1,170
Gajewski, T. F., & Fitch, F. W. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.12.4245 · Cited by 834
Schleimer, R. P., Sterbinsky, S. A., Kaiser, J., Bickel, C. A., Klunk, D. A., Tomioka, K., Newman, W., Luscinskas, F. W., Gimbrone, M. A., & McIntyre, B. W. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.4.1086 · Cited by 818
Kay, A. B., Ying, S., Varney, V, Gaga, M., Durham, S. R., Moqbel, R., Wardlaw, A. J., & Hamid, Q. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.775 · Cited by 659
Self-citationPhysiological and Molecular Mechanisms of Lymphocyte Homing
Picker, L. J., & Butcher, E. C. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.003021 · Cited by 657
Control of scarring in adult wounds by neutralising antibody to transforming growth factor β
Shah, M., Foreman, D. M., & Ferguson, M. W. J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90009-r · Cited by 613
Cited by
New insights into atopic dermatitis
Leung, D. Y. M., Boguniewicz, M., Howell, M. D., Nomura, I., & Hamid, Q. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21060 · Cited by 1,435
“Analyses of biopsies from clinically unaffected skin of AD patients, as compared with normal nonatopic skin, demonstrate an increased number of Th2 cells expressing IL-4 and IL-13, but not IFN-γ, mRNA (6).”
Self-citationLeung, D. Y., & Bieber, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12193-9 · Cited by 1,147
Self-citationCytokine modulation of atopic dermatitis filaggrin skin expression
Howell, M. D., Kim, B. E., Gao, P., Grant, A. V., Boguniewicz, M., DeBenedetto, A., Schneider, L., Beck, L. A., Barnes, K. C., & Leung, D. Y. M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.031 · Cited by 1,084
Self-citationGittler, J. K., Shemer, A., Suárez-Fariñas, M., Fuentes-Duculan, J., Gulewicz, K. J., Wang, C. Q. F., Mitsui, H., Cardinale, I., de Guzman Strong, C., Krueger, J. G., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.012 · Cited by 981
“However, it has been extremely difficult to perform studies on true acuteAD lesions becausemost patients with AD present with only chronic lesions (defined as persisting for >72 hours).(16) In turn, most studies of ‘‘acute’’ disease changes have examined skin inflammation induced by topical application of environmenta…”
BackgroundAdult Chronic Rhinosinusitis: Definitions, Diagnosis, Epidemiology, and Pathophysiology
(2003) · Otolaryngology–Head and Neck Surgery · doi:10.1016/s0194-5998(03)01397-4 · Cited by 942
Food allergy. Part 1: Immunopathogenesis and clinical disorders
Sampson, H. A. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70411-2 · Cited by 816
Targeting key proximal drivers of type 2 inflammation in disease
Gandhi, N. A., Bennett, B. L., Graham, N. M. H., Pirozzi, G., Stahl, N., & Yancopoulos, G. D. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd4624 · Cited by 766
Tight junction defects in patients with atopic dermatitis
De Benedetto, A., Rafaels, N. M., McGirt, L. Y., Ivanov, A. I., Georas, S. N., Cheadle, C., Berger, A. E., Zhang, K., Vidyasagar, S., Yoshida, T., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.018 · Cited by 747
Self-citationAkdis, C. A., Akdis, M., Bieber, T., Bindslev‐Jensen, C., Boguniewicz, M., Eigenmann, P., Hamid, Q., Kapp, A., Leung, D. Y. M., Lipozencic, J., et al. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01153.x · Cited by 733
Self-citationNomura, I., Goleva, E., Howell, M. D., Hamid, Q. A., Ong, P. Y., Hall, C. F., Darst, M. A., Gao, B., Boguniewicz, M., Travers, J. B., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3262 · Cited by 731
Self-citationA role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis
Grewe, M., Bruijnzeel-Koomen, C. A. F. M., Schöpf, E., Thepen, T., Langeveld-Wildschut, A. G., Ruzicka, T., & Krutmann, J. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01285-7 · Cited by 723
Atopic dermatitis: New insights and opportunities for therapeutic intervention
Leung, D. Y. M. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.106484 · Cited by 721
Self-citationThe immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies
Brunner, P. M., Guttman-Yassky, E., & Leung, D. Y. M. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.011 · Cited by 642
Self-citationSpergel, J. M., Mizoguchi, E., Brewer, J. P., Martin, T. R., Bhan, A. K., & Geha, R. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1647 · Cited by 640
Emerging Functions of Amphiregulin in Orchestrating Immunity, Inflammation, and Tissue Repair
Zaiss, D. M. W., Gause, W. C., Osborne, L. C., & Artis, D. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.020 · Cited by 638
Bieber, T. (2010) · Annals of Dermatology · doi:10.5021/ad.2010.22.2.125 · Cited by 557
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
Kim, B. E., Leung, D. Y. M., Boguniewicz, M., & Howell, M. D. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.11.006 · Cited by 538
Self-citationTrautmann, A., Akdis, M., Kleemann, D., Altznauer, F., Simon, H.-U., Graeve, T., Noll, M., Bröcker, E.-B., Blaser, K., & Akdis, C. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9199 · Cited by 495
Deciphering the complexities of atopic dermatitis: Shifting paradigms in treatment approaches
Leung, D. Y. M., & Guttman-Yassky, E. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.008 · Cited by 474
Self-citationCytokine modulation of atopic dermatitis filaggrin skin expression
Howell, M. D., Kim, B. E., Gao, P., Grant, A. V., Boguniewicz, M., DeBenedetto, A., Schneider, L., Beck, L. A., Barnes, K. C., & Leung, D. Y. M. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.07.012 · Cited by 473
Self-citationIgE, Mast Cells, and Eosinophils in Atopic Dermatitis
Liu, F.-T., Goodarzi, H., & Chen, H.-Y. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-011-8252-4 · Cited by 470
Suárez-Fariñas, M., Tintle, S. J., Shemer, A., Chiricozzi, A., Nograles, K., Cardinale, I., Duan, S., Bowcock, A. M., Krueger, J. G., & Guttman-Yassky, E. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.1124 · Cited by 464
Akdis, C. A., Akdis, M., Bieber, T., Bindslev-Jensen, C., Boguniewicz, M., Eigenmann, P., Hamid, Q., Kapp, A., Leung, D. Y. M., Lipozencic, J., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.03.045 · Cited by 460
Self-citationThepen, T., Langeveld-Wildschut, E. G., Bihari, I. C., Wichen, D. F. V., Reijsen, F. C. V., Mudde, G. C., & Bruijnzeel-Koomen, C. A. F. M. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)80161-8 · Cited by 404
Significance of Skin Barrier Dysfunction in Atopic Dermatitis
Kim, B. E., & Leung, D. Y. M. (2018) · Allergy, Asthma & Immunology Research · doi:10.4168/aair.2018.10.3.207 · Cited by 393
“cytokines that contribute to skin barrier dysfunction by altering protein and lipid content in the skin (Table 1).(2,4,57,58) FLG is a key epidermal barrier protein.”
BackgroundSelf-citationContrasting pathogenesis of atopic dermatitis and psoriasis—Part I: Clinical and pathologic concepts
Guttman-Yassky, E., Nograles, K. E., & Krueger, J. G. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.053 · Cited by 384
Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis
Bieber, T. (2020) · Allergy · doi:10.1111/all.13954 · Cited by 382
In vivo expression of IL-12 and IL-13 in atopic dermatitis
Hamid, Q., Naseer, T., Minshall, E. M., Song, Y. L., Boguniewicz, M., & Leung, D. Y. M. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70246-4 · Cited by 382
Self-citationNeis, M. M., Peters, B., Dreuw, A., Wenzel, J., Bieber, T., Mauch, C., Krieg, T., Stanzel, S., Heinrich, P. C., Merk, H. F., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.07.015 · Cited by 378
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
Mollanazar, N. K., Smith, P. K., & Yosipovitch, G. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8488-5 · Cited by 353
Vestergaard, C., Bang, K., Gesser, B., Yoneyama, H., Matsushima, K., & Larsen, C. G. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00115.x · Cited by 349
Cytokine Milieu of Atopic Dermatitis Skin Subverts the Innate Immune Response to Vaccinia Virus
Howell, M. D., Gallo, R. L., Boguniewicz, M., Jones, J. F., Wong, C., Streib, J. E., & Leung, D. Y. M. (2006) · Immunity · doi:10.1016/j.immuni.2006.02.006 · Cited by 335
Self-citationSicherer, S. H., & Sampson, H. A. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70053-9 · Cited by 333
To respond or not to respond: T cells in allergic asthma
Herrick, C. A., & Bottomly, K. (2003) · Nature Reviews Immunology · doi:10.1038/nri1084 · Cited by 333
Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis
Nomura, I., Gao, B., Boguniewicz, M., Darst, M. A., Travers, J. B., & Leung, D. Y. M. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.049 · Cited by 332
Self-citationRecent insights into atopic dermatitis and implications for management of infectious complications
Boguniewicz, M., & Leung, D. Y. M. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.11.027 · Cited by 329
Self-citationJAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
Huang, I.-H., Chung, W.-H., Wu, P.-C., & Chen, C.-B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1068260 · Cited by 329
Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies
Furue, M., Chiba, T., Tsuji, G., Ulzii, D., Kido-Nakahara, M., Nakahara, T., & Kadono, T. (2017) · Allergology International · doi:10.1016/j.alit.2016.12.002 · Cited by 324
Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection
Fishbein, A. B., Silverberg, J. I., Wilson, E. J., & Ong, P. Y. (2020) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.06.044 · Cited by 321
Boguniewicz, M., Fiedler, V. C., Raimer, S., Lawrence, I. D., Leung, D. Y. M., & Hanifin, J. M. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70281-7 · Cited by 309
Self-citationGlucocorticoids—All-Rounders Tackling the Versatile Players of the Immune System
Strehl, C., Ehlers, L., Gaber, T., & Buttgereit, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01744 · Cited by 308
“The substantial role of the type 2 response in the pathogenesis of allergic diseases has also been highlighted by the examination of samples from patients suffering from AD (186), AR (187), and asthma (188–191) demonstrating the preponderance of Th2 cells and cytokines in the affected tissues.”
BackgroundPathogenesis of atopic dermatitis
Leung, D. Y. M. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70051-5 · Cited by 306
Self-citationChan, L. S., Robinson, N., & Xu, L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01484.x · Cited by 306
Cytokines and the Skin Barrier
Hänel, K., Cornelissen, C., Lüscher, B., & Baron, J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14046720 · Cited by 305
Beneficial Effects of Marine Algal Compounds in Cosmeceuticals
Thomas, N., & Kim, S.-K. (2013) · Marine Drugs · doi:10.3390/md11010146 · Cited by 302
Maintenance of Hair Follicle Immune Privilege Is Linked to Prevention of NK Cell Attack
Ito, T., Ito, N., Saatoff, M., Hashizume, H., Fukamizu, H., Nickoloff, B. J., Takigawa, M., & Paus, R. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701183 · Cited by 300
de Jongh, G. J., Zeeuwen, P. L. J. M., Kucharekova, M., Pfundt, R., van der Valk, P. G., Blokx, W., Dogan, A., Hiemstra, P. S., van de Kerkhof, P. C., & Schalkwijk, J. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23935.x · Cited by 285
Schmid(‐Grendelmeier), P., Simon, D., Simon, H., Akdis, C. A., & Wüthrich, B. (2001) · Allergy · doi:10.1034/j.1398-9995.2001.00144.x · Cited by 279
Cho, S.-H., Strickland, I., Boguniewicz, M., & Leung, D. Y. M. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.117455 · Cited by 275
Self-citationCathelicidin deficiency predisposes to eczema herpeticum
Howell, M. D., Wollenberg, A., Gallo, R. L., Flaig, M., Streib, J. E., Wong, C., Pavicic, T., Boguniewicz, M., & Leung, D. Y. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.12.1345 · Cited by 275
Self-citationThymus and activation regulated chemokine (TARC)/CCL17 and skin diseases
Saeki, H., & Tamaki, K. (2006) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2006.06.002 · Cited by 272
Phenotype of atopic dermatitis subjects with a history of eczema herpeticum
Beck, L. A., Boguniewicz, M., Hata, T., Schneider, L. C., Hanifin, J., Gallo, R., Paller, A. S., Lieff, S., Reese, J., Zaccaro, D., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.020 · Cited by 260
Self-citationGueniche, A., Knaudt, B., Schuck, E., Volz, T., Bastien, P., Martin, R., Röcken, M., Breton, L., & Biedermann, T. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08836.x · Cited by 247
Th2 Cytokines Act on S100/A11 to Downregulate Keratinocyte Differentiation
Howell, M. D., Fairchild, H. R., Kim, B. E., Bin, L., Boguniewicz, M., Redzic, J. S., Hansen, K. C., & Leung, D. Y. M. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.74 · Cited by 224
“Acute AD skin is characterized by the over-expression of interleukin (IL)-4 and IL-13 (Hamid et al., 1994; Homey et al., 2006).”
Self-citationMechanism of HBD-3 deficiency in atopic dermatitis
Howell, M. D., Boguniewicz, M., Pastore, S., Novak, N., Bieber, T., Girolomoni, G., & Leung, D. Y. M. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.08.008 · Cited by 208
Self-citationHerrick, C. A., MacLeod, H., Glusac, E., Tigelaar, R. E., & Bottomly, K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8624 · Cited by 180
Portugal, M., Barak, V., Ginsburg, I., & Kohen, R. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.05.010 · Cited by 121
Are mast cells instrumental for fibrotic diseases?
Overed-Sayer, C., Rapley, L., Mustelin, T., & Clarke, D. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00174 · Cited by 105
Iwasaki, M., Nagata, K., Takano, S., Takahashi, K., Ishii, N., & Ikezawa, Z. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01862.x · Cited by 86
A small molecule CRTH2 antagonist inhibits FITC-induced allergic cutaneous inflammation
Boehme, S. A., Franz-Bacon, K., Chen, E. P., Sasik, R., Sprague, L. J., Ly, T. W., Hardiman, G., & Bacon, K. B. (2009) · International Immunology · doi:10.1093/intimm/dxn127 · Cited by 60
“control patients (4) and an increased expression of Th2 cytokines, including IL-4, IL-5, IL-13 and tumor necrosis factor-a (TNF-a) ( 5 ).”
BackgroundThe skin microbiome in pediatric atopic dermatitis and food allergy
Tham, E. H., Chia, M., Riggioni, C., Nagarajan, N., Common, J. E. A., & Kong, H. H. (2024) · Allergy · doi:10.1111/all.16044 · Cited by 38
Immunological pathomechanisms of spongiotic dermatitis in skin lesions of atopic dermatitis
Tanei, R., & Hasegawa, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126682 · Cited by 33
“In addition, macrophages that capture HDM antigens are thought to be a source of the secreted IL-12 that induces a shift to Th1 immunity [44].”
BackgroundElentner, A., Schmuth, M., Yannoutsos, N., Eichmann, T. O., Gruber, R., Radner, F. P. W., Hermann, M., Del Frari, B., & Dubrac, S. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.07.846 · Cited by 27
“K14-VPPXR keratinocytes express more TSLP and secrete more GM-CSF, whereas the percentages of skin-derived T lymphocytes producing IL-13 and IL-17A are increased in mice when compared with controls, similar to what is observed in AD (Hamid et al., 1994; Kim, 2015a; Leung and Guttman-Yassky, 2014; Werfel, 2009).”
BackgroundResult
Metadata
- Authors
- Hamid, Q., Boguniewicz, M., & Leung, D. Y.
- Venue
- Journal of Clinical Investigation
- Published
- 1994-08-01
- Volume
- 94
- Issue
- 2
- Pages
- 870-876
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1984366394
- Cited by
- 778
- References
- 36
- FWCI
- 23.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.